american heart association glp 1 GLP-1 drugs can help you lose weight. They can't do this. A new statement, just published in JAMA, makes a point that doesn't get nearly enough attention in the Adipose Tissue Plasticity, Lipoprotein Metabolism,

Enzymes in the bloodstream degrade it within minutes of release, limiting its therapeutic potential

SUMMARY With the recent completion of large, prospective, double-blind, placebo-controlled cardiovascular outcome studies, we have moved into a new era of diabetes treatment in which antidiabetic medications that both reduce glycemia, thereby preventing microvascular complications, and prevent macrovascular complications (MI, stroke, CV mortality) should be considered as first line therapy for the treatment of T2DM patients at high cardiovascular risk

In particular, we need to support our livers Phase II detoxification pathway to ensure toxins released from our bodys fat storage in Phase I are not released and recycled, adding to our livers already toxic load

(PubMed) Gerstenberger JP, Bauer SR, Van Blarigan EL, et al

Sitagliptin and liraglutide modulate l-dopa effect and attenuate dyskinetic movements in rotenone-lesioned rats

Furthermore, illustrative photomicrographs for a given diagnostic entity may occasionally depict additional tissue changes as this reflects actual situations frequently observed in pathological evaluation of toxicity studies